Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P080025/S352

InterStim Therapy System, Verify Evaluation System

Medtronic Neuromodulation · Decision date Sep 14, 2026

MEDTECHLEDGER EXPLANATIONP080025/S352

What did the FDA decide?

FDA database entry P080025/S352 records a 30-Day Notice for the InterStim Therapy System and Verify Evaluation System. The decision, dated September 14, 2026, is OK30, and the stated change is the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers.

The supplement type is a Process Change involving manufacturer, sterilizer, packager, or supplier. The applicant is Medtronic Neuromodulation. The source statement reports the purpose of the notice but does not provide independent proof of safety or clinical effectiveness, and no new indication or clinical benefit is stated.

FDA approval order statement

the addition of a manufacturing verification step for the WR9220A and P720R1 wireless rechargers
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 14, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P080025/S352
Regulatory pathway
PMA supplement
Product code
QON
Decision code
OK30
Decision date
Sep 14, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implanted electrical device intended for treatment of fecal incontinence.

Product code
QON
FDA device class
3

For the original device and its historical approval scope, see PMA P080025. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P080025 · Original PMA

    MEDTRONIC INTERSTIM SACRAL NERVE STIMULATION THERAPY SYSTEM

  2. P080025/S352 received

    Application receipt date recorded by FDA.

  3. P080025/S352 · FDA decision

    30-Day Notice

  4. P080025/S351 · Related supplement

    lnterStim Therapy System, Verify Evaluation System

  5. P080025/S353 · Related supplement

    InterStim Therapy System, Verify Evaluation System

  6. P080025/S354 · Related supplement

    InterStim Therapy System, Verify Evaluation System (SNS Bowel Neurostimulator 97800), (SNS Bowel Neurostimulators Impl

Timeline entries are records held by MedtechLedger for P080025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P080025

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Neuromodulation

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
7000 Central Ave., NE, Ms Rcw225, Minneapolis, MN, 55432

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records